SPEVIGO
SPEVIGO
Approved
DIN Number
02550296
Drug Class
Human
Market Date
Oct 28, 2024
Company
HC
boehringer ingelheim (canada) ltd ltee
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02550296
AIG Number0164521002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L04AC22 SPESOLIMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification84:06.28
Health Canada Classification
ACTIVE INGREDIENTS (1)
SPESOLIMABActive
Strength: 150 MG / ML
Monograph: SPESOLIMAB